Pregnancy outcomes in women with moderate-to-severe psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 9, 2011, Pages 1041-1047

  Cohen Barak, E ^a   Nachum, Z ^a,b   Rozenman, D ^a   Ziv, M ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

abortions; birth weight; hypertension; macrosomia; pregnancy outcome; psoriasis

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH BIRTH WEIGHT; HUMAN; INDUCED ABORTION; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL HYPERTENSION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; RISK FACTOR; SPONTANEOUS ABORTION;

ADULT; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PSORIASIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 80051682924     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03917.x     Document Type: Article

References (50)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Augustin M, Reich K, Glaeske G, et al. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-151.
3. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58: 826-850. (Pubitemid 351509656)
4. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73. (Pubitemid 46934281)
5. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741. (Pubitemid 44547793)
6. Xiao J, Chen LH, Tu YT, et al. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311-1315.
7. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-1006.
8. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534. (Pubitemid 41815842)
9. Cohen AD, Sherf M, Vidavsky DA, et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152-155. (Pubitemid 351158580)
10. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835. (Pubitemid 44556851)
11. Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-634. (Pubitemid 46400186)
12. Dreiher J, Weitzman D, Shapiro J, et al. Psoriasis and chronic obstructive pulmonary disease: a case-control study. Br J Dermatol 2008; 159: 956-960.
13. Dreiher J, Weitzman D, Cohen AD,. Psoriasis and osteoporosis: a sex-specific association? Invest Dermatol 2009; 129: 1643-1649.
14. Bandoli G, Johnson DL, Jones KL, et al. Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. Br J Dermatol 2010; 163: 334-339.
15. Reece EA, Leguizamón G, Wiznitzer A,. Gestational diabetes: the need for a common ground. Lancet 2009; 373: 1789-1797.
16. Duckitt K, Harrington D,. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565.
17. Kwak-Kim JY, Gilman-Sachs A, Kim CE,. T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy 2005; 88: 64-79. (Pubitemid 43094377)
18. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA,. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007; 133: 1106-1112. (Pubitemid 47494456)
19. Kaplan D,. Fetal wastage in patients with rheumatoid arthritis. J Rheumatol 1986; 13: 875-877. (Pubitemid 17203917)
20. Georgio PE, Politj EN, Katsimbri P, et al. Outcomes of lupus pregnancy: a controlled study. Rhematology (Oxford) 2000; 39: 1014-1019.
21. Petri M, Allbritton J,. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins lupus cohort. J Rheumatol 1993; 20: 650-656. (Pubitemid 23138853)
22. Cortés-Hernández J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002; 41: 643-650. (Pubitemid 34618882)
23. Horn EJ, Chambers CD, Menter A, Kimball AB, International Psoriasis Council. Pregnancy outcomes in psoriasis: why do we know so little? J Am Acad Dermatol 2009; 61: e5-8.
24. Seeger JD, Lanza LL, West WA, et al. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology 2007; 214: 32-39. (Pubitemid 46032998)
25. Ben-David G, Sheiner E, Hallak M, Levy A,. Pregnancy outcome in women with psoriasis. J Reprod Med 2008; 53: 183-187. (Pubitemid 351498127)
26. Jagou M, Bastuji-Garin S, Bourdon-Lanoy E, Penso-Assathiany D, Roujeau JC, Réseau d'Epidémiologie en Dermatologie (RED). Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses. Br J Dermatol 2006; 155: 1006-1012. (Pubitemid 44564512)
27. Cassano N, Buquicchio R, Ranieri V, et al. Is there an association between antiphospholipid antibodies and psoriasis? J Biol Regul Homeost Agents 2008; 22: 207-210.
28. Lam J, Polifka JE, Dohil MA,. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J Am Acad Dermatol 2008; 59: 295-315.
29. Kwak-Kim J, Yang KM, Gilman-Sachs A,. Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynaecol Res 2009; 35: 609-622.
30. Duley L,. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137.
31. Goldenberg RL, Culhane JF, Iams JD, Romero R,. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
32. Callaway LK, O'Callaghan M, McIntyre HD,. Obesity and the hypertensive disorders of pregnancy. Hypertens Pregnancy 2009; 28: 473-493.
33. Shirazian T, Raghavan S,. Obesity and pregnancy: implications and management strategies for providers. Mt Sinai J Med 2009; 76: 539-545.
34. Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB,. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol 2009; 34: 140-144.
35. Huang YH, Yang LC, Hui RY, et al. Relationships between obesity and the clinical severity of psoriasis in Taiwan. J Eur Acad Dermatol Venereol 2010; 24: 1035-1039.
36. Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53: 944-951.
37. Garovic VD, Bailey KR, Boerwinkle E, Hunt SC, Weder AB, Curb D,. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens 2010; 28: 826-833.
38. Garovic VD, Hayman SR,. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007; 3: 613-622. (Pubitemid 350012820)
39. Wikström AK, Haglund B, Olovsson M, Lindeberg SN,. The risk of maternal ischemic heart disease after gestational hypertensive disease. BJOG 2005; 112: 1486-1491. (Pubitemid 43961234)
40. Arnadottir GA, Geirsson RT, Arngrimsson R, et al. Cardiovascular death in women who had hypertension in pregnancy: a case-control study. BJOG 2005; 112: 286-292. (Pubitemid 40314002)
41. Henriksen T,. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 2008; 87: 134-145. (Pubitemid 351171533)
42. Zamorski MA, Biggs WS,. Management of suspected fetal macrosomia. Am Fam Physician 2001; 63: 302-306. (Pubitemid 32147026)
43. Jaipaul JV, Newburn-Cook CV, O'Brien B, Demianczuk N,. Modifiable risk factors for term large for gestational age births. Health Care Women Int 2009; 30: 802-823.
44. Ju H, Chadha Y, Donovan T, O'Rourke P,. Fetal macrosomia and pregnancy outcomes. Aust NZ J Obstet Gynaecol 2009; 49: 504-509.
45. Stoll BJ, Chapman IA,. The high-risk infant. In, Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics, 18th edn. Saunders, Fort Worth, TX, 2007: 710-711.
46. Araz N, Araz M,. Frequency of neonatal hypoglycemia in large for gestational age infants of non-diabetic mothers in a community maternity hospital. Acta Medica (Hradec Kralove) 2006; 49: 237-239.
47. Schaefer-Graf UM, Rossi R, Bührer C, et al. Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers. Am J Obstet Gynecol 2002; 187: 913-917. (Pubitemid 35178382)
48. Surkan PJ, Hsieh CC, Johansson AL, et al. Reasons for increasing trends in large for gestational age births. Obstet Gynecol 2004; 104: 720-726. (Pubitemid 40458799)
49. Bergmann RL, Richter R, Bergmann KE, et al. Secular trends in neonatal macrosomia in Berlin: influences of potential determinants. Paediatr Perinat Epidemiol 2003; 17: 244-249. (Pubitemid 36827921)
50. Baraban E, McCoy L, Simon P,. Increasing prevalence of gestational diabetes and pregnancy-related hypertension in Los Angeles County, California, 1991-2003. Prev Chronic Dis 2008; 5: A77.